Cantex Pharmaceuticals, Inc. - Net Worth and Insider Trading

Cantex Pharmaceuticals, Inc. Net Worth

The estimated net worth of Cantex Pharmaceuticals, Inc. is at least $4 Million dollars as of 2023-12-04. Cantex Pharmaceuticals, Inc. is the 10% Owner of Chimerix Inc and owns about 3,500,000 shares of Chimerix Inc (CMRX) stock worth over $4 Million. Details can be seen in Cantex Pharmaceuticals, Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cantex Pharmaceuticals, Inc. has not made any transactions after 2021-09-14 and currently still holds the listed stock(s).

Transaction Summary of Cantex Pharmaceuticals, Inc.

To

Cantex Pharmaceuticals, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cantex Pharmaceuticals, Inc. owns 1 companies in total, including Chimerix Inc () .

Click here to see the complete history of Cantex Pharmaceuticals, Inc.’s form 4 insider trades.

Insider Ownership Summary of Cantex Pharmaceuticals, Inc.

Ticker Comapny Transaction Date Type of Owner
Chimerix Inc 2021-09-14 10 percent owner

Cantex Pharmaceuticals, Inc. Latest Holdings Summary

Cantex Pharmaceuticals, Inc. currently owns a total of 1 stock. Cantex Pharmaceuticals, Inc. owns 3,500,000 shares of Chimerix Inc (CMRX) as of September 14, 2021, with a value of $4 Million.

Latest Holdings of Cantex Pharmaceuticals, Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CMRX Chimerix Inc 2021-09-14 3,500,000 1.01 3,517,500

Holding Weightings of Cantex Pharmaceuticals, Inc.


Cantex Pharmaceuticals, Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Cantex Pharmaceuticals, Inc. has made a total of 1 transactions in Chimerix Inc (CMRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Chimerix Inc is the sale of 6,500,000 shares on September 14, 2021, which brought Cantex Pharmaceuticals, Inc. around $37 Million.

Insider Trading History of Cantex Pharmaceuticals, Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cantex Pharmaceuticals, Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cantex Pharmaceuticals, Inc. Ownership Network

Ownership Network List of Cantex Pharmaceuticals, Inc.

No Data

Ownership Network Relation of Cantex Pharmaceuticals, Inc.


Cantex Pharmaceuticals, Inc. Owned Company Details

What does Chimerix Inc do?

Who are the key executives at Chimerix Inc?

Cantex Pharmaceuticals, Inc. is the 10 percent owner of Chimerix Inc. Other key executives at Chimerix Inc include Principal Accounting Officer David Jakeman , director & Chief Executive Officer Michael A. Sherman , and Chief Business Officer Michael T. Andriole .

Chimerix Inc () Insider Trades Summary

Over the past 18 months, Cantex Pharmaceuticals, Inc. made no insider transaction in Chimerix Inc (). Other recent insider transactions involving Chimerix Inc () include a net purchase of 80,000 shares made by Fred A Middleton , a net sale of 11,240 shares made by David Jakeman , and a net purchase of 87,000 shares made by Michael A. Sherman .

In summary, during the past 3 months, insiders sold 3,610 shares of Chimerix Inc () in total and bought 40,000 shares, with a net purchase of 36,390 shares. During the past 18 months, 11,240 shares of Chimerix Inc () were sold and 193,750 shares were bought by its insiders, resulting in a net purchase of 182,510 shares.

Chimerix Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Chimerix Inc Insider Transactions

No Available Data

Cantex Pharmaceuticals, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Cantex Pharmaceuticals, Inc.. You might contact Cantex Pharmaceuticals, Inc. via mailing address: 1792 Bell Tower Lane, Suite 222, Weston Fl 33326.

Discussions on Cantex Pharmaceuticals, Inc.

No discussions yet.